- /
- Supported exchanges
- / US
- / MDT.NYSE
Medtronic PLC (MDT NYSE) stock market data APIs
Medtronic PLC Financial Data Overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring sys
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Medtronic PLC (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Medtronic PLC data using free add-ons & libraries
Get Medtronic PLC Fundamental Data
Medtronic PLC Fundamental data includes:
- Net Revenue: 37 542 M
- EBITDA: 10 392 M
- Earnings Per Share: 4
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-09-01
- EPS/Forecast: 1.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Medtronic PLC News
New
MDT Q2 Earnings Preview: Will Cardiovascular Performance Lift Results?
Medtronic plc MDT is slated to report its second-quarter fiscal 2027 results on Nov. 24, before the opening bell. The company posted earnings per share (EPS) of $1.45 in the last reported quarter, wh...
Medtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system
An expanded U.S. 510(k) extends the Hugo™ RAS system's reach into one of the fastest-growing areas of U.S. robotic surgery. GALWAY, Ireland, Nov. 17, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT),...
Why Is Medtronic (MDT) Buying A Carotid Device Specialist?
Medtronic (NYSE:MDT) plans to acquire Contego Medical, a carotid artery disease device specialist, as announced in November 2026. The deal would add Contego's FDA approved carotid and peripheral vascu...
Nvidia board needs 'some heavyweights,' ex-Medtronic CEO Bill George says
The embattled Nvidia (NVDA) board should have two trains running on the same tracks right now. One train is out searching for the next CEO. The other is looking for more experienced board members to...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.